North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2032

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Size

• The North America cardiac monitoring and cardiac rhythm management devices market size was valued at USD 2.42 billion in 2024 and is expected to reach USD 3.29 billion by 2032, at a CAGR of 3.90% during the forecast period
• The market growth is largely fueled by the increasing prevalence of cardiovascular diseases, coupled with the rising need for continuous patient monitoring and timely therapeutic interventions. Advances in digital health technologies, including implantable devices, wearable monitors, and remote monitoring systems, are driving adoption across hospitals and home healthcare settings
• Furthermore, growing awareness among healthcare providers and patients about early detection of arrhythmias, heart failure, and other cardiac conditions is boosting demand for cardiac monitoring and rhythm management solutions. Continuous innovations in device miniaturization, connectivity, and integration with telehealth platforms are enhancing patient outcomes. These converging factors are accelerating the adoption of cardiac monitoring and cardiac rhythm management devices, thereby significantly boosting the industry's growth

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Analysis

• Cardiac monitoring and cardiac rhythm management devices, including implantable and wearable solutions, are increasingly vital components of modern healthcare systems in both clinical and home settings due to their ability to provide continuous, real-time monitoring, early detection of cardiac abnormalities, and seamless integration with digital health platforms
• The escalating demand for cardiac monitoring and cardiac rhythm management devices is primarily fueled by the increasing prevalence of cardiovascular diseases, rising awareness about heart health, and growing adoption of advanced medical technologies for continuous patient monitoring
• U.S. dominated the cardiac monitoring and cardiac rhythm management devices market with the largest revenue share of 74.8% in 2024, driven by advanced healthcare infrastructure, high prevalence of cardiac disorders, and strong adoption of innovative devices such as implantable cardioverter defibrillators (ICDs), pacemakers, and wearable cardiac monitors. The U.S. market benefits from frequent product launches, technological advancements, and robust reimbursement frameworks, ensuring widespread patient access to modern cardiac care solutions
• Canada is expected to be the fastest-growing country in the cardiac monitoring and cardiac rhythm management devices market during the forecast period, projected to register a strong CAGR of 7.8%, fueled by rising government initiatives to improve cardiac care services, increasing access to hospitals and specialty clinics, and growing awareness about preventive cardiology and remote patient monitoring. The adoption of next-generation wearable devices and telemonitoring technologies is further accelerating market growth in the country
• The Pacemakers segment dominated the cardiac monitoring and cardiac rhythm management devices market with the largest market revenue share of 32.5% in 2024, driven by their widespread clinical use for treating bradycardia and other heart rhythm disorders

Report Scope and Cardiac Monitoring and Cardiac Rhythm Management Devices Market Segmentation    

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Trends

Enhanced Convenience Through Advanced Cardiac Monitoring Technologies

• A significant and accelerating trend in the U.S. cardiac monitoring and cardiac rhythm management devices market is the increasing integration of advanced monitoring systems, including wearable and implantable devices, with digital health platforms. This integration is significantly enhancing patient convenience, continuous monitoring, and real-time clinical insights
  • For instance, modern implantable cardioverter defibrillators (ICDs) and pacemakers now come equipped with remote monitoring capabilities, enabling clinicians to track patient heart rhythms in real time, detect abnormalities early, and adjust treatment plans promptly. Similarly, wearable cardiac monitors provide non-invasive continuous heart rate and rhythm tracking, offering patients greater control over their health management
• Advanced cardiac monitoring devices are increasingly equipped with features that allow automated alerts for irregular heart rhythms, personalized health notifications, and detailed activity logs. These functionalities support proactive intervention, reduce hospital visits, and improve overall patient outcomes
• The seamless integration of cardiac monitoring devices with mobile and cloud-based health platforms allows centralized tracking of multiple health parameters. Through a single interface, clinicians and patients can access heart rhythm data, medication adherence logs, and historical trends, enabling a comprehensive and coordinated care approach
• This trend towards more connected, reliable, and user-friendly cardiac monitoring systems is fundamentally reshaping patient expectations for heart care. Consequently, companies such as Medtronic and Boston Scientific are developing solutions with real-time remote monitoring, automated alerts, and interoperability with electronic health records
• The demand for advanced cardiac monitoring and rhythm management devices is growing rapidly across hospitals, specialty clinics, and home healthcare settings, as patients and clinicians increasingly prioritize convenience, accuracy, and continuous care management

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Dynamics

Driver

Growing Need Due to Rising Prevalence of Cardiovascular Diseases and Remote Monitoring Adoption

• The increasing prevalence of cardiovascular disorders such as arrhythmias, heart failure, and other chronic conditions, coupled with the rising adoption of remote patient monitoring solutions, is a significant driver for the heightened demand for cardiac monitoring and cardiac rhythm management devices
  • For instance, in April 2024, PROCEPT BioRobotics announced the FDA clearance of its next-generation Hydros Robotic System for Aquablation therapy, reflecting ongoing innovations in minimally invasive cardiac and urological procedures. Such strategies by key companies are expected to drive the Cardiac Monitoring and Cardiac Rhythm Management Devices industry growth in the forecast period
• As healthcare providers and patients become more aware of the importance of continuous cardiac monitoring, advanced devices such as implantable loop recorders, wearable ECG monitors, and mobile cardiac telemetry systems offer timely detection of arrhythmias, facilitating early interventions and reducing hospital readmissions
• Furthermore, the integration of these devices with telehealth platforms and remote monitoring applications is enabling real-time data transmission, enabling cardiologists to monitor patients’ heart health remotely and adjust treatments proactively
• The convenience of minimally invasive procedures, continuous monitoring, real-time alerts, and the ability to share cardiac data with healthcare providers are key factors propelling the adoption of these devices in hospitals, home healthcare settings, and ambulatory care centers. The trend towards connected healthcare solutions and patient-centric monitoring devices further contributes to market growth

Restraint/Challenge

Concerns Regarding Device Complexity and High Initial Costs

• Concerns surrounding the complexity of certain implantable and monitoring devices pose a challenge to broader market adoption. Advanced cardiac devices often require specialized training for implantation or programming, which can limit accessibility in smaller healthcare facilities
  • For instance, high upfront costs of devices such as implantable loop recorders, cardiac resynchronization therapy (CRT) systems, and advanced defibrillators can be a barrier for hospitals or patients with budget constraints
• Addressing these challenges through user-friendly device designs, streamlined implantation procedures, robust training programs for clinicians, and the development of more cost-effective solutions is crucial for wider adoption. In addition, ensuring device reliability, long-term monitoring accuracy, and patient compliance are critical factors for maintaining trust and effectiveness
• While costs are gradually decreasing and remote monitoring capabilities are improving, perceived complexity and initial investment requirements can still hinder widespread adoption, particularly in smaller clinics or developing regions
• Overcoming these challenges through simplified device interfaces, integration with telehealth platforms, insurance coverage support, and educational programs for both clinicians and patients will be vital for sustained growth in the cardiac monitoring and cardiac rhythm management devices market

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Scope

The market is segmented on the basis of product and end-user.

• By Product

On the basis of product, the cardiac monitoring and cardiac rhythm management devices market is segmented into ECG Devices, Implantable Loop Recorders, Cardiac Output Monitoring (COM) Devices, Event Monitors, Mobile Cardiac Telemetry Monitoring (MCT/MCOT), Smart Wearable ECG Monitors, Defibrillators, Pacemakers, and Cardiac Resynchronization Therapy (CRT) devices. The Pacemakers segment dominated the largest market revenue share of 32.5% in 2024, driven by their widespread clinical use for treating bradycardia and other heart rhythm disorders. Pacemakers are highly preferred due to their proven efficacy, reliability, and continuous technological innovations such as rate-adaptive pacing and MRI compatibility. The robust adoption in hospitals and specialty clinics, combined with strong reimbursement frameworks and a growing elderly population in North America, reinforces their leading position in the market. Continuous product launches and improvements in device longevity further strengthen the pacemaker segment’s dominance.

The Smart Wearable ECG Monitors segment is anticipated to witness the fastest growth rate, registering a CAGR of 15.8% from 2025 to 2032, fueled by rising consumer awareness about cardiovascular health and the increasing adoption of home monitoring solutions. These devices provide real-time heart rate and rhythm monitoring, integrating seamlessly with mobile apps for remote tracking by physicians. Their portability, non-invasive design, and ease of use make them highly suitable for ambulatory patients and individuals at risk of arrhythmias. The increasing preference for preventive cardiac care, combined with technological innovations such as AI-assisted anomaly detection and cloud data analytics, is driving rapid adoption in both clinical and home settings.

• By End-User

On the basis of end-user, the cardiac monitoring and cardiac rhythm management devices market is segmented into hospitals, home and ambulatory care settings, and others. The Hospitals segment accounted for the largest market revenue share of 58.3% in 2024, attributed to the high volume of cardiac patients requiring continuous monitoring, sophisticated device implantation, and post-operative care. Hospitals provide specialized infrastructure, trained healthcare professionals, and advanced diagnostic capabilities, enabling widespread adoption of complex devices such as pacemakers, CRT devices, and defibrillators. The presence of well-established cardiology departments, strong reimbursement policies, and regular device upgrades contribute to sustained revenue dominance in this segment. Hospitals also benefit from large-scale procurement contracts, further reinforcing their market leadership.

The home and ambulatory care settings segment is expected to witness the fastest CAGR of 14.6% from 2025 to 2032, driven by the growing preference for remote cardiac monitoring and outpatient care solutions. With the increasing focus on reducing hospital readmissions, wearable and mobile cardiac monitoring devices are gaining traction among patients and healthcare providers. These settings allow continuous monitoring of heart rhythm disorders, early detection of anomalies, and timely physician intervention, providing convenience and improved quality of care. Technological advancements, combined with rising consumer awareness about self-monitoring and preventive healthcare, are accelerating growth in this segment.

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Regional Analysis

• North America dominated the cardiac monitoring and cardiac rhythm management devices market with the largest revenue share in 2024
• Driven by advanced healthcare infrastructure, a high prevalence of cardiac disorders, and the growing adoption of innovative devices such as implantable cardioverter defibrillators (ICDs), pacemakers, and wearable cardiac monitors
• The market in the region is further supported by frequent product launches, continuous technological advancements, and robust reimbursement frameworks, ensuring widespread patient access to modern cardiac care solutions

U.S. Cardiac Monitoring and Cardiac Rhythm Management Devices Market Insight

The U.S. cardiac monitoring and cardiac rhythm management devices market captured the largest revenue share of 74.8% in 2024 within North America, fueled by the strong adoption of advanced cardiac monitoring and rhythm management technologies. Key growth drivers include high awareness of cardiovascular diseases, a technologically advanced healthcare ecosystem, and the increasing use of implantable and wearable cardiac devices for continuous patient monitoring. Frequent launches of innovative devices, including next-generation pacemakers, ICDs, CRT systems, and smart wearable ECG monitors, coupled with strong reimbursement policies, are further propelling market growth. Integration of telehealth and remote monitoring platforms enables real-time patient tracking, supporting early intervention, improved treatment adherence, and enhanced clinical outcomes, further reinforcing the U.S. market dominance.

Canada Cardiac Monitoring and Cardiac Rhythm Management Devices Market Insight

The Canada cardiac monitoring and cardiac rhythm management devices market is expected to be the fastest-growing country in the North America market during the forecast period, projected to register a CAGR of 7.8%, driven by government initiatives to strengthen cardiac care services, improve access to hospitals and specialty clinics, and promote preventive cardiology. The adoption of next-generation wearable cardiac monitors and telemonitoring technologies is further accelerating growth, enabling continuous patient monitoring, early detection of arrhythmias, and timely clinical interventions. Growing awareness among patients and healthcare providers about remote cardiac care, combined with rising investments in digital health solutions, is expected to sustain Canada’s strong market growth throughout the forecast period.

North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market Share

The cardiac monitoring and cardiac rhythm management devices industry is primarily led by well-established companies, including:

• GENERAL ELECTRIC COMPANY(U.S.)
• Abbott (U.S.)
• Boston Scientific Corporation (U.S.)
• SCHILLER AG(Switzerland)
• Koninklijke Philips N.V. (Netherlands)
• Biotronik SE & Co., KG (Germany)
• ABIOMED (U.S.)
• NIHON KOHDEN CORPORATION (Japan)
• ReliantHeart Inc. (U.S.)
• Berlin Heart (Germany)
• Jarvik Heart, Inc. (U.S.)
• LivaNova PLC (U.K.)
• ZOLL Medical Corporation (U.S.)
• Edwards Lifesciences Corporation (U.S.)
• Getinge AB (Sweden)

Latest Developments in North America Cardiac Monitoring and Cardiac Rhythm Management Devices Market

• In December 2024, HeartBeam, Inc., a medical technology firm dedicated to advancing cardiac care through innovative diagnostic tools, announced that it had secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its HeartBeam system. This device offers comprehensive arrhythmia detection with a unique, patented approach, featuring high-fidelity electrocardiogram (ECG) capability within a compact, credit card-sized, wireless design. The HeartBeam system enables the capture of heart activity from three different angles, delivering critical insights into cardiac health
• In May 2024, the Heart Rhythm Society (HRS) announced new findings around several clinical trials showcasing recent advancements in cardiac implantable electronic device (CIED) technology and pharmacotherapy. These studies, presented as late-breaking clinical science during Heart Rhythm 2024, highlighted developments that overcome the limitations of traditional devices or address unmet therapeutic needs
• In April 2024, Abbott launched the world's first smartphone-compatible implantable heart monitor, the Confirm Rx ICM. This device offers more accurate detection of heart rhythm disorders and provides patients with a smarter approach to 24/7 heart monitoring. The Confirm Rx ICM is designed to seamlessly integrate with smartphones, allowing for real-time data sharing and enhanced patient engagement

SKU-1850